Evidence map›Paper›PMID 40418540›Full record

ArticleCurrent protocols2025

Generation of Conformation-Specific Monoclonal Antibodies for Integral Membrane Proteins.

Natalie Sheldon, Gunasekaran Dhandapani, Junhoe Kim, Cathy J Spangler, Chengli Fang, Jumi Park, Prashant Rao, Eric Gouaux

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Dimeric gold nanoparticles enable multiplexed labeling in cryoelectron tomography.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Natalie SheldonVollum Institute, Oregon Health & Science University, Portland, Oregon.
Gunasekaran DhandapaniVollum Institute, Oregon Health & Science University, Portland, Oregon.
Junhoe KimVollum Institute, Oregon Health & Science University, Portland, Oregon.
Cathy J SpanglerVollum Institute, Oregon Health & Science University, Portland, Oregon.
Chengli FangVollum Institute, Oregon Health & Science University, Portland, Oregon.
Jumi ParkVollum Institute, Oregon Health & Science University, Portland, Oregon.
Prashant RaoVollum Institute, Oregon Health & Science University, Portland, Oregon.
Eric GouauxVollum Institute, Oregon Health & Science University, Portland, Oregon.ORCID https://orcid.org/0000-0002-8549-2360

Funding

3D STRUCTURE/FUNCTION OF LIGAND GATED ION CHANNELSR01NS038631 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 1999 to 2024
$6.7M
3D Structure and Function of Ligand-Gated Ion ChannelsR37NS038631 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI James E Gouaux · 2009 to 2026
$4.1M
Characterization of native AMPA receptor structure and function in glioblastomaK00CA253730 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI SPANGLER, CATHERINE JEANETTE · 2022 to 2025
$409k
NCI NIH HHS K00 CA253730NINDS NIH HHS R01 NS038631NINDS NIH HHS R37 NS038631
6 · The paper itself

Abstract

Antibodies and their antigen-binding fragments, including fragment antigen-binding domains (Fabs) and single-chain variable fragments (scFvs), are extraordinary tools in all fields of biology, particularly in neuroscience, where they have been utilized for imaging, detection, and quantification studies. Most antibodies bind to unstructured or linear epitopes. Conformation-specific antibodies, by contrast, bind to 3D epitopes, recognizing native conformations of the target antigen, and have proven highly useful in X-ray crystallography as crystallization chaperones and in cryo-electron microscopy as fiducial markers. Moreover, because conformation-specific antibodies recognize 3D shapes of the antigen, they often have exquisite specificity and are useful in immunofluorescence studies and in isolation of antigen from native tissues. Over the past decade, our group has devoted effort to developing murine monoclonal antibodies (mAbs) against important synaptic receptors, particularly ionotropic glutamate receptors (iGluRs) and their auxiliary proteins. We have developed reproducible methods for generating high-quality mAbs for structural, biochemical, and imaging studies. In this article, we show how to prepare proteoliposomes (PLs), carry out immunization and track the immune response, perform hybridoma generation, and analyze the specificity, cross-reactivity, and competition of mAb binding via enzyme-linked immunosorbent assay and fluorescence-detection size-exclusion chromatography. Our PL-based method produces high-affinity, conformation-specific antibodies targeting diverse synaptic membrane receptors in 4 months. Here, we describe the relevant protocols in detail and document the mAbs, Fabs, and scFvs that we have produced against iGluRs and their auxiliary subunits. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Generation of conformation-specific antibodies for integral membrane proteins Support Protocol 1: Detection of conformational antibodies using ELISA Basic Protocol 2: Expression and purification of monoclonal antibodies and their derivatives Support Protocol 2: Concentration and clarification of insect cell supernatant for Fab purification Support Protocol 3: Measurement of ionotropic glutamate receptor binding kinetics using Octet BLI System.

Indexed as

Antibodies, MonoclonalMembrane ProteinsAnimalsHumansHybridomasMiceProtein ConformationAntibodies, MonoclonalMembrane Proteinscrystallization chaperonesfragment antigen‐binding regionglutamate receptorsproteoliposomessingle‐chain variable fragment

Identifiers

PMID40418540
PMCPMC12105683

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.